| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 1-Feb-09 | | Total Revenue | 16,361,000 | 19,071,000 | 16,175,000 | 14,607,000 | | Cost of Revenue | 10,800,000 | 12,683,000 | 10,725,000 | 9,647,000 | | | Gross Profit | 5,561,000 | 6,388,000 | 5,450,000 | 4,960,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,870,000 | 4,121,000 | 4,042,000 | 4,251,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 428,000 | 434,000 | 428,000 | 443,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,263,000 | 1,833,000 | 980,000 | 266,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | 6,000 | 5,000 | (158,000) | | Earnings Before Interest And Taxes | 1,267,000 | 1,839,000 | 985,000 | 108,000 | | Interest Expense | 168,000 | 167,000 | 180,000 | 139,000 | | Income Before Tax | 1,099,000 | 1,672,000 | 805,000 | (31,000) | | Income Tax Expense | 410,000 | 556,000 | 291,000 | (29,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 689,000 | 1,116,000 | 514,000 | (2,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (52,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 689,000 | 1,116,000 | 514,000 | (54,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $689,000 | $1,116,000 | $514,000 | ($54,000) |
|
0.35% Nasdaq 
Income Statement
